226 results on '"Morélot-Panzini, Capucine"'
Search Results
2. Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial
3. "In their own words": delineating the contours of dyspnea invisibility in patients with advanced chronic obstructive pulmonary disease from quantitative discourse analysis
4. Severity and phenotypes of dyspnea in asthma: Impact of comorbidities
5. Respiratory distress observation scales to predict weaning outcome
6. Position paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021
7. Dyspnoea-12 and Multidimensional Dyspnea Profile: Systematic Review of Use and Properties
8. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study
9. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study
10. Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: A cross-sectional cohort.
11. Sensory interventions to relieve dyspnoea in critically ill mechanically ventilated patients
12. Dyspnoea relief as an inherent benefit of high flow nasal cannula therapy: A laboratory randomized trial in healthy humans
13. Mandibular advancement reveals long-term suppression of breathing discomfort in patients with obstructive sleep apnea syndrome
14. Survival of amyotrophic lateral sclerosis patients after admission to the intensive care unit for acute respiratory failure: an observational cohort study
15. The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear
16. Dyspnoea relief as an inherent benefit of high flow nasal cannula therapy: A laboratory randomized trial in healthy humans.
17. 18 F-FDG uptake by respiratory muscles in acute respiratory insufficiency in a patient with graft versus host disease
18. 18F-FDG uptake by respiratory muscles in acute respiratory insufficiency in a patient with graft versus host disease
19. Nefopam, a non-opioid analgesic, does not alleviate experimental work/effort dyspnoea in healthy humans: A randomised controlled trial
20. Short-term cognitive loading deteriorates breathing pattern and gas exchange in adult patients with congenital central hypoventilation syndrome
21. ‘Involve me and I learn’: an experiential teaching approach to improve dyspnea awareness in medical residents
22. ‘You can’t feel what we feel’: Multifaceted dyspnoea invisibility in advanced chronic obstructive pulmonary disease examined through interpretative phenomenological analysis
23. Prognostic Value of the Intensive Care Respiratory Distress Observation Scale on ICU Admission
24. sj-pdf-1-pmj-10.1177_02692163221118198 – Supplemental material for ‘You can’t feel what we feel’: Multifaceted dyspnoea invisibility in advanced chronic obstructive pulmonary disease examined through interpretative phenomenological analysis
25. Additional file 1 of Respiratory distress observation scales to predict weaning outcome
26. Lower Rate of Daily Smokers With Symptomatic COVID-19: A Monocentric Self-Report of Smoking Habit Study
27. Impact of inspiratory threshold loading on brain activity and cognitive performances in healthy humans
28. Lifting dyspnoea invisibility: COVID-19 face masks, the experience of breathing discomfort, and improved lung health perception – a French nationwide survey
29. Unrecognized suffering in the ICU: addressing dyspnea in mechanically ventilated patients
30. Scalene muscle activity during progressive inspiratory loading under pressure support ventilation in normal humans
31. Facemasks as a COVID-19 barrier: a window into the overlooked experience of chronic dyspnoea?
32. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study
33. Reversal of pulmonary hypertension after diaphragm pacing in an adult patient with congenital central hypoventilation syndrome
34. Effects of muscle group recruitment on sniff transdiaphragmatic pressure and its components
35. Intrathoracic phrenic pacing: A 10-year experience in France
36. Dyspnea: The vanished warning symptom of COVID‐19 pneumonia
37. Low rate of daily smokers in patients with symptomatic COVID-19
38. Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study
39. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
40. Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension
41. Implanted Phrenic Stimulation Impairs Local Diaphragm Myofiber Reinnervation in Amyotrophic Lateral Sclerosis
42. Simplified Method to Measure Respiratory-Related Changes in Arterial Pulse Pressure in Patients Receiving Mechanical Ventilation*
43. Human diaphragm atrophy in amyotrophic lateral sclerosis is not predicted by routine respiratory measures
44. Respiratory‐related cortical activity in patients with COPD and aged normal individuals: towards a different vision of dyspnoea?
45. Management of Dyspnea in the Noncommunicative Patients
46. No Benefit of Diaphragm Pacing in Upper Motor Neuron–Dominant Forms of Amyotrophic Lateral Sclerosis
47. The Mechanical Ventilation–Respiratory Distress Observation Scale as a surrogate of self-reported dyspnoea in intubated patients
48. Normal sleep on mechanical ventilation in adult patients with congenital central alveolar hypoventilation (Ondine's curse syndrome)
49. The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.
50. Dyspnoea modifies the recognition of fearful expressions by healthy humans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.